2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 515

Are Changes in Autoantibody Levels Reflecting Change in Prognosis of Rheumatoid Arthritis?
Abstract Number: 2093

Are General and Central Adiposity Associated with MRI-Assessed Structural Changes in the Knees of Older Adults?
Abstract Number: 689

Are Individual or Country Level Socio-Economic Determinants Related to Disease Activity and Self-Reported Physical Function in Patients with Spondyloarthritis – Results from Multi-National Cross-Sectional Study Comospa
Abstract Number: 331

Are Metabolic Factors Associated with Shoulder Osteoarthritis? a Multicentric Study.
Abstract Number: 272

Are the Autoimmune/Inflammatory Syndrome Induced By Adjuvants (ASIA) and the Undifferentiated Connective Tissue Disease (UCTD) Related to Each Other? a Case-Control Study of Environmental Exposures
Abstract Number: 1898

Are There Risk Factors for Calcinosis in Scleroderma?
Abstract Number: 1542

Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis
Abstract Number: 801

Artesunate Modulates Atherosclerosis Related Factors through the Inhibition of STAT1
Abstract Number: 2385

Arthritis Management in Primary Care and Adherence to National Guidelines – a Swedish Survey Based on the Canadian Physiotherapists Arthritis Care Questionnaire
Abstract Number: 661

ASDAS Can be Reliably Calculated When Only the Patient’s Overall Basdai Score Is Available, but Not the Score(S) of Its Individual Component(S)
Abstract Number: 650

ASDAS-Based Remission Was Less Frequent Than Basdai-Based Remission, and Both Were Related to CRP and Smoking in Early Axial Spondyloarthritis
Abstract Number: 916

Assessing Alternative Selection Criteria for Fibromyalgia Patients within a Multicenter Chronic Pain Claims Database
Abstract Number: 2661

Assessing Information Needs for Chronic Disease Management in Rheumatoid Arthritis
Abstract Number: 1332

Assessing Radiographic Damage in Ankylosing Spondylitis: Variability in Reliability of the Modified Stoke Ankylosing Spondylitis Spine Score According to the Statistical Method
Abstract Number: 1226

Assessing the Possible Association of Anti-TNF Use with New Neoplasms: An Important Methodological Consideration

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].